Herbal Medicines - A Fruitful Approach to Periodic Illness Dysmenorrhoea: Evidence-based Review
- Authors: Bansal K.1, Sharma S.1, Bajpai M.1
-
Affiliations:
- Institute of Pharmaceutical Research, GLA University
- Issue: Vol 25, No 2 (2024)
- Pages: 179-195
- Section: Biotechnology
- URL: https://rjsocmed.com/1389-2010/article/view/644748
- DOI: https://doi.org/10.2174/1389201024666230623161113
- ID: 644748
Cite item
Full Text
Abstract
Dysmenorrhea (menstrual or periodic pain) is a discomfort that occurs during painful periods. It is the first and most prominent reason for female lower abdominal pain. Most adolescent girls consider it a curse due to the periodic occurrence of painful cramps and bleeding. The pathogenesis of painful periods is most likely because of increased prostanoids, notably prostaglandins, produced by the cyclooxygenase pathway (PGs). Misuse of synthetic medications leads to the development of medication resistance and deposits toxic residues in the body; thus, there is a critical need for safe and effective alternatives. In recent decades, herbal treatment approaches have found extensive applications in the treatment of various ailments. Herbal therapies are an alternate source, which include several bioactive chemicals, and recent improvements in our understanding of the value of herbal therapy methods have caused a sharp rise in their production. The main focus of this review was to study herbal treatment options; the recent studies conducted on herbal therapies and various experimental investigations on dysmenorrhea and herbal therapy methods have been studied, and randomized controlled trials and animal models have been discussed describing the anti-inflammatory properties of some potential herbal medicines that can be used as treatment options for dysmenorrhoea. This review aimed to present herbal treatments that can be used as alternative traditional synthetic medications and oral hormonal contraceptives in the treatment of painful menstruation.
About the authors
Keshav Bansal
Institute of Pharmaceutical Research, GLA University
Author for correspondence.
Email: info@benthamscience.net
Sachin Sharma
Institute of Pharmaceutical Research, GLA University
Email: info@benthamscience.net
Meenakshi Bajpai
Institute of Pharmaceutical Research, GLA University
Email: info@benthamscience.net
References
- Guimarães, I.; Póvoa, A.M. Primary dysmenorrhea: assessment and treatment. Rev. Bras. Ginecol. Obstet., 2020, 42(8), 501-507. doi: 10.1055/s-0040-1712131 PMID: 32559803
- Ferries-Rowe, E.; Corey, E.; Archer, J.S. Primary Dysmenorrhea. Obstet. Gynecol., 2020, 136(5), 1047-1058. doi: 10.1097/AOG.0000000000004096 PMID: 33030880
- Gupta, R.; Gupta, J.; Kumar, D. Alternative approaches for rheumatoid arthritis management: future perspective, herbal, dietary, lifestyle, psychological, nutritional intervention and healthcare. J. Pharm. Res. Int., 2021, 33(54A), 342-363. doi: 10.9734/jpri/2021/v33i54A33756
- Gupta, R.; Sharma, S. herbal antibiotics: a review. bulletin of environment. Pharmacol Life Sci., 2020, 9(11), 136-142.
- Itani, R.; Soubra, L.; Karout, S.; Rahme, D.; Karout, L.; Khojah, H.M.J. Primary dysmenorrhea: pathophysiology, diagnosis, and treatment updates. Korean J. Fam. Med., 2022, 43(2), 101-108. doi: 10.4082/kjfm.21.0103 PMID: 35320895
- Gutman, G.; Nunez, A.T.; Fisher, M. Dysmenorrhea in adolescents. Curr. Probl. Pediatr. Adolesc. Health Care, 2022, 52(5), 101186. doi: 10.1016/j.cppeds.2022.101186 PMID: 35523674
- Davis, A.R.; Westhoff, C.L. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J. Pediatr. Adolesc. Gynecol., 2001, 14(1), 3-8. doi: 10.1016/S1083-3188(00)00076-0 PMID: 11358700
- Dawood, M.Y. Primary Dysmenorrhea. Obstet. Gynecol., 2006, 108(2), 428-441. doi: 10.1097/01.AOG.0000230214.26638.0c PMID: 16880317
- Schoep, M.E.; Adang, E.M.M.; Maas, J.W.M.; De Bie, B.; Aarts, J.W.M.; Nieboer, T.E. Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women. BMJ Open, 2019, 9(6), e026186. doi: 10.1136/bmjopen-2018-026186 PMID: 31248919
- Morrow, C.; Naumburg, E.H. Dysmenorrhea. Prim. Care, 2009, 36(1), 19-32. vii. doi: 10.1016/j.pop.2008.10.004 PMID: 19231600
- Friederich, M.A. Dysmenorrhoea.In lifting the curse of menstruation a feminist appraisal of the influence of menstruation on womens lives New York: Routeledge; Golub, S., Ed.; Taylor and Francis: London, 2017, pp. 91-106. doi: 10.4324/9781315866116-5
- Harel, Z. Dysmenorrhea in adolescents and young adults: etiology and management. J. Pediatr. Adolesc. Gynecol., 2006, 19(6), 363-371. doi: 10.1016/j.jpag.2006.09.001 PMID: 17174824
- Osayande, A.S.; Mehulic, S. Diagnosis and initial management of dysmenorrhea. Am. Fam. Physician, 2014, 89(5), 341-346. PMID: 24695505
- Weissman, A.M.; Hartz, A.J.; Hansen, M.D.; Johnson, S.R. The natural history of primary dysmenorrhoea: a longitudinal study. BJOG, 2004, 111(4), 345-352. doi: 10.1111/j.1471-0528.2004.00090.x PMID: 15008771
- Sachedin, A.; Todd, N. Dysmenorrhea, endometriosis and chronic pelvic pain in adolescents. J. Clin. Res. Pediatr. Endocrinol., 2020, 12(1), 7-17. doi: 10.4274/jcrpe.galenos.2019.2019.S0217 PMID: 32041388
- Durain, D. Primary dysmenorrhea: assessment and management update. J. Midwifery Womens Health, 2004, 49(6), 520-528. doi: 10.1016/j.jmwh.2004.08.013 PMID: 15544981
- Sanfilippo, J.; Erb, T. Evaluation and management of dysmenorrhea in adolescents. Clin. Obstet. Gynecol., 2008, 51(2), 257-267. doi: 10.1097/GRF.0b013e31816d2307 PMID: 18463457
- Doty, E.; Attaran, M. Managing primary dysmenorrhea. J. Pediatr. Adolesc. Gynecol., 2006, 19(5), 341-344. doi: 10.1016/j.jpag.2006.06.005 PMID: 17060018
- Iacovides, S.; Avidon, I.; Baker, F.C. What we know about primary dysmenorrhea today: a critical review. Hum. Reprod. Update, 2015, 21(6), 762-778. doi: 10.1093/humupd/dmv039 PMID: 26346058
- Ruoff, G.; Lema, M. Strategies in pain management: new and potential indications for COX-2 specific inhibitors. J. Pain Symptom Manage., 2003, 25(2)(Suppl.), 21-31. doi: 10.1016/S0885-3924(02)00628-0 PMID: 12604154
- French, L. Dysmenorrhea in Adolescents. Paediatr. Drugs, 2008, 10(1), 1-7. doi: 10.2165/00148581-200810010-00001 PMID: 18162003
- Granot, M.; Yarnitsky, D.; Itskovitz-Eldor, J.; Granovsky, Y.; Peer, E.; Zimmer, E.Z. Pain perception in women with dysmenorrhea. Obstet. Gynecol., 2001, 98(3), 407-411. PMID: 11530120
- Ju, H.; Jones, M.; Mishra, G. The prevalence and risk factors of dysmenorrhea. Epidemiol. Rev., 2014, 36(1), 104-113. doi: 10.1093/epirev/mxt009 PMID: 24284871
- Wang, L.; Yan, Y.; Qiu, H.; Xu, D.; Zhu, J.; Liu, J. Prevalence and risk factors of primary dysmenorrhea in students: a meta-analysis. Value Health, 2022, 2022, S1098-S3015. doi: 10.1016/j.jval.2022.03.023
- Ohde, S.; Tokuda, Y.; Takahashi, O.; Yanai, H.; Hinohara, S.; Fukui, T. Dysmenorrhea among Japanese women. Int. J. Gynaecol. Obstet., 2008, 100(1), 13-17. doi: 10.1016/j.ijgo.2007.06.039 PMID: 17888923
- Wang, L.; Wang, X.; Wang, W.; Chen, C.; Ronnennberg, A.G.; Guang, W.; Huang, A.; Fang, Z.; Zang, T.; Wang, L.; Xu, X. Stress and dysmenorrhoea: a population based prospective study. Occup. Environ. Med., 2004, 61(12), 1021-1026. doi: 10.1136/oem.2003.012302 PMID: 15550609
- Abenhaim, H.A.; Harlow, B.L. Live births, cesarean sections and the development of menstrual abnormalities. Int. J. Gynaecol. Obstet., 2006, 92(2), 111-116. doi: 10.1016/j.ijgo.2005.10.011 PMID: 16376346
- Burnett, M.A.; Antao, V.; Black, A.; Feldman, K.; Grenville, A.; Lea, R.; Lefebvre, G.; Pinsonneault, O.; Robert, M. Prevalence of primary dysmenorrhea in Canada. J. Obstet. Gynaecol. Can., 2005, 27(8), 765-770. doi: 10.1016/S1701-2163(16)30728-9 PMID: 16287008
- Harlow, B.L.; Missmer, S.A.; Cramer, D.W.; Barbieri, R.L. Does tubal sterilization influence the subsequent risk of menorrhagia or dysmenorrhea? Fertil. Steril., 2002, 77(4), 754-760. doi: 10.1016/S0015-0282(01)03253-8 PMID: 11937129
- László, K.D. GyŐrffy, Z.; Ádám, S.; Csoboth, C.; Kopp, M.S. Work-related stress factors and menstrual pain: a nation-wide representative survey. J. Psychosom. Obstet. Gynaecol., 2008, 29(2), 133-138. doi: 10.1080/01674820701804423 PMID: 18484442
- László, K.D.; Kopp, M.S. Effort-reward imbalance and overcommitment at work are associated with painful menstruation: results from the Hungarostudy Epidemiological Panel 2006. J. Occup. Environ. Med., 2009, 51(2), 157-163. doi: 10.1097/JOM.0b013e318197ca89 PMID: 19209036
- Nohara, M.; Momoeda, M.; Kubota, T.; Nakabayashi, M. Menstrual cycle and menstrual pain problems and related risk factors among Japanese female workers. Ind. Health, 2010, (Aug), 1012100044. PMID: 21173526
- Patel, V.; Tanksale, V.; Sahasrabhojanee, M.; Gupte, S.; Nevrekar, P. The burden and determinants of dysmenorrhoea: a population-based survey of 2262 women in Goa, India. BJOG, 2006, 113(4), 453-463. doi: 10.1111/j.1471-0528.2006.00874.x PMID: 16489934
- Pawłowski, B. Prevalence of menstrual pain in relation to the reproductive life history of women from the Mayan rural community. Ann. Hum. Biol., 2004, 31(1), 1-8. doi: 10.1080/03014460310001602072 PMID: 14742161
- Vivian, D.; Barnard, A. Prevalence and correlates of three types of pelvic pain in a nationally representative sample of Australian women. Med. J. Aust., 2009, 190(1), 47-48. doi: 10.5694/j.1326-5377.2009.tb02269.x PMID: 19266629
- Santer, M.; Warner, P.; Wyke, S. A Scottish postal survey suggested that the prevailing clinical preoccupation with heavy periods does not reflect the epidemiology of reported symptoms and problems. J. Clin. Epidemiol., 2005, 58(11), 1206-1210. doi: 10.1016/j.jclinepi.2005.02.026 PMID: 16223665
- Tavallaee, M.; Joffres, M.R.; Corber, S.J.; Bayanzadeh, M.; Rad, M.M. The prevalence of menstrual pain and associated risk factors among Iranian women. J. Obstet. Gynaecol. Res., 2011, 37(5), 442-451. doi: 10.1111/j.1447-0756.2010.01362.x PMID: 21208343
- Unsal, A.; Tozun, M.; Aslan, G.; Ayranci, U.; Alkan, G. Evaluation of dysmenorrhea among women and its impact on quality of life in a region of western turkey. Pak. J. Med. Sci., 2010, 26(1), 142-147.
- Coco, A.S. Primary dysmenorrhea. Am. Fam. Physician, 1999, 60(2), 489-496. PMID: 10465224
- Feng, X.; Wang, X. Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs for patients with primary dysmenorrhea: A network meta-analysis. Mol. Pain, 2018, 14(111) doi: 10.1177/1744806918770320 PMID: 29587566
- Marjoribanks, J.; Proctor, M.L.; Farquhar, C.; Sangkomkamhang, U.S.; Derks, R.S. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst. Rev., 2003, (4), CD001751. PMID: 14583938
- McCOOL WF. W.F. Varneys midwifery, 4th Edi; Jones and bartlett publishers, 2004.
- Bulletin, A.P. ACOG Practice Bulletin No. 110: noncontraceptive uses of hormonal contraceptives. Obstet. Gynecol., 2010, 115(1), 206-218. doi: 10.1097/AOG.0b013e3181cb50b5 PMID: 20027071
- Burnett, M.; Lemyre, M. No. 345-Primary Dysmenorrhea Consensus Guideline. J. Obstet. Gynaecol. Can., 2017, 39(7), 585-595. doi: 10.1016/j.jogc.2016.12.023 PMID: 28625286
- Stewart, F.H.; Kaunitz, A.M.; LaGuardia, K.D.; Karvois, D.L.; Fisher, A.C.; Friedman, A.J. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial. Obstet. Gynecol., 2005, 105(6), 1389-1396. doi: 10.1097/01.AOG.0000160430.61799.f6 PMID: 15932834
- Milsom, I.; Lete, I.; Bjertnaes, A.; Rokstad, K.; Lindh, I.; Gruber, C.J.; Birkhäuser, M.H.; Aubeny, E.; Knudsen, T.; Bastianelli, C. Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 g ethinyl estradiol and 3 mg drospirenone. Hum. Reprod., 2006, 21(9), 2304-2311. doi: 10.1093/humrep/del162 PMID: 16763008
- Dunn, N. Oral contraceptives and venous thromboembolism. BMJ, 2009, 339(aug13 2), b3164. doi: 10.1136/bmj.b3164 PMID: 19679617
- Sergison, J.E.; Maldonado, L.Y.; Gao, X.; Hubacher, D. Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis. Am. J. Obstet. Gynecol., 2019, 220(5), 440-448.e8. doi: 10.1016/j.ajog.2018.12.008 PMID: 30527945
- Hubacher, D.; Lopez, L.; Steiner, M.J.; Dorflinger, L. Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons. Contraception, 2009, 80(2), 113-118. doi: 10.1016/j.contraception.2009.02.008 PMID: 19631785
- Berenson, A.B.; Rahman, M.; Breitkopf, C.R.; Bi, L.X. Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density. Obstet. Gynecol., 2008, 112(4), 788-799. doi: 10.1097/AOG.0b013e3181875b78 PMID: 18827121
- Hansen, S.O.; Knudsen, U.B. Endometriosis, dysmenorrhoea and diet. Eur. J. Obstet. Gynecol. Reprod. Biol., 2013, 169(2), 162-171. doi: 10.1016/j.ejogrb.2013.03.028 PMID: 23642910
- Pattanittum, P.; Kunyanone, N.; Brown, J.; Sangkomkamhang, U.S.; Barnes, J.; Seyfoddin, V.; Marjoribanks, J. Dietary supplements for dysmenorrhoea. Cochrane Database Syst. Rev., 2016, 3(3), CD002124. PMID: 27000311
- Armour, M.; Ee, C.C.; Naidoo, D.; Ayati, Z.; Chalmers, K.J.; Steel, K.A.; de Manincor, M.J.; Delshad, E. Exercise for dysmenorrhoea. Cochrane Database Syst. Rev., 2019, 9(9), CD004142. PMID: 31538328
- Al-Husban, N.; Odeh, O.; Dabit, T.; Masadeh, A. The Influence of Lifestyle Variables on Primary Dysmenorrhea: A Cross-Sectional Study. Int. J. Womens Health, 2022, 14, 545-553. doi: 10.2147/IJWH.S338651 PMID: 35444471
- Jo, J.; Lee, S.H. Heat therapy for primary dysmenorrhea: A systematic review and meta-analysis of its effects on pain relief and quality of life. Sci. Rep., 2018, 8(1), 16252. doi: 10.1038/s41598-018-34303-z PMID: 30389956
- Potur, D.C.; Kömürcü, N. The effects of local low-dose heat application on dysmenorrhea. J. Pediatr. Adolesc. Gynecol., 2014, 27(4), 216-221. doi: 10.1016/j.jpag.2013.11.003 PMID: 24656704
- Arik, M.I.; Kiloatar, H.; Aslan, B.; Icelli, M. The effect of TENS for pain relief in women with primary dysmenorrhea: A systematic review and meta-analysis. Explore (NY), 2022, 18(1), 108-113. doi: 10.1016/j.explore.2020.08.005 PMID: 32917532
- Elboim-Gabyzon, M.; Kalichman, L. Transcutaneous electrical nerve stimulation (tens) for primary dysmenorrhea: An Overview. Int. J. Womens Health, 2020, 12, 1-10. doi: 10.2147/IJWH.S220523 PMID: 32021488
- Zhao, L.; Li, P. A survey of acupuncture treatment for primary dysmenorrhea. J. Tradit. Chin. Med., 2009, 29(1), 71-76. doi: 10.1016/S0254-6272(09)60035-2 PMID: 19514193
- Smith, C.A.; Armour, M.; Zhu, X.; Li, X.; Lu, Z.Y.; Song, J. Acupuncture for dysmenorrhoea. Cochrane Database Syst. Rev., 2016, 4(4), CD007854. PMID: 27087494
- Proctor, M.; Farquhar, C. Diagnosis and management of dysmenorrhoea. BMJ, 2006, 332(7550), 1134-1138. doi: 10.1136/bmj.332.7550.1134 PMID: 16690671
- Wyatt, S.N.; Banahan, T.; Tang, Y.; Nadendla, K.; Szychowski, J.M.; Jenkins, T.R. Effect of radiofrequency endometrial ablation on dysmenorrhea. J. Minim. Invasive Gynecol., 2016, 23(7), 1163-1166. doi: 10.1016/j.jmig.2016.08.825 PMID: 27590567
- Darwish, M.; Atlantis, E.; Mohamed-Taysir, T. Psychological outcomes after hysterectomy for benign conditions: a systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol., 2014, 174(1), 5-19. doi: 10.1016/j.ejogrb.2013.12.017 PMID: 24398028
- Bougie, O.; Suen, M.W.; Pudwell, J.; MacGregor, B.; Plante, S.; Nitsch, R.; Singh, S.S. Evaluating the prevalence of regret with the decision to proceed with a hysterectomy in women younger than age 35. J. Obstet. Gynaecol. Can., 2020, 42(3), 262-268.e3. doi: 10.1016/j.jogc.2019.08.006 PMID: 31734156
- Jaleel, G.; Shaphe, M.A.; Khan, A.R.; Malhotra, D.; Khan, H.; Parveen, S.; Qasheesh, M.; Beg, R.A.; Chahal, A.; Ahmad, F.; Ahmad, M.F. Effect of exercises on central and endocrine system for pain modulation in primary dysmenorrhea. J. Lifestyle Med., 2022, 12(1), 15-25. doi: 10.15280/jlm.2022.12.1.15 PMID: 35300040
- Morgan, P.J.; Kung, R.; Tarshis, J. Nitroglycerin as a uterine relaxant: a systematic review. J. Obstet. Gynaecol. Can., 2002, 24(5), 403-409. doi: 10.1016/S1701-2163(16)30403-0 PMID: 12196860
- Moya, R.A.; Moisa, C.F.; Morales, F.; Wynter, H.; Ali, A.; Narancio, E. Transdermal glyceryl trinitrate in the management of primary dysmenorrhea. Int. J. Gynaecol. Obstet., 2000, 69(2), 113-118. doi: 10.1016/S0020-7292(00)00185-5 PMID: 10802078
- Proctor, M.L.; Murphy, P.A. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst. Rev., 2001, (3), CD002124. PMID: 11687013
- Ziaei, S.; Faghihzadeh, S.; Sohrabvand, F.; Lamyian, M.; Emamgholy, T. A randomised placebo-controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhoea. BJOG, 2001, 108(11), 1181-1183. doi: 10.1111/j.1471-0528.2003.00279.x PMID: 11762659
- Jahangirifar, M.; Taebi, M.; Dolatian, M. The effect of Cinnamon on primary dysmenorrhea: A randomized, double-blind clinical trial. Complement. Ther. Clin. Pract., 2018, 33(33), 56-60. doi: 10.1016/j.ctcp.2018.08.001 PMID: 30396627
- Vinodoni, R.; Hazel, A.A.; Sundaram, M.M.; Banumathi, V. Therapeutic potency of Siddha herbomineral preparation SiddhadhiEnnai on gynaecological diseasesa review. World J. Pharm. Pharm. Sci., 2018, 7(10), 969-979.
- Adib Rad, H.; Basirat, Z.; Bakouei, F.; Moghadamnia, A.A.; Khafri, S.; Farhadi Kotenaei, Z.; Nikpour, M.; Kazemi, S. Effect of Ginger and Novafen on menstrual pain: A cross-over trial. Taiwan. J. Obstet. Gynecol., 2018, 57(6), 806-809. doi: 10.1016/j.tjog.2018.10.006 PMID: 30545531
- Jose, B.; Jesy, E.J.; Nedumpara, R.J. Evaluation of the DPPH free radical scavenging activity of Wrightia tinctoria R. Br. leaf, bark and seed extracts. World J. Pharm. Res., 2014, 3(3), 5041-5048.
- Liao, J.; Deng, J.; Chiu, C.; Hou, W.; Huang, S.; Shie, P. Anti-inflammatory activities of cinnamomum cassia constituents In vitro and In vivo. Evid. Based Compl. Alter. Med., 2012, 2022, 1-12.
- Jeena, K.; Liju, V.B.; Kuttan, R. Antioxidant, anti-inflammatory and antinociceptive activities of essential oil from ginger. Indian J. Physiol. Pharmacol., 2013, 57(1), 51-62. PMID: 24020099
- Grzanna, R.; Lindmark, L.; Frondoza, C.G. Ginger--an herbal medicinal product with broad anti-inflammatory actions. J. Med. Food, 2005, 8(2), 125-132. doi: 10.1089/jmf.2005.8.125 PMID: 16117603
- Kumar, A.; Singh, A.K. Trachyspermum Ammi (Ajwain): A Comprehensive Review. World J. Pharm. Res., 2021, 10(6), 724-736.
- Umar, S.; Asif, M.; Sajad, M.; Ansari, M.M.; Hussain, U.; Ahmad, W.; Siddiqui, S.A.; Ahmad, S.; Khan, H.A. Anti-inflammatory and antioxidant activity of Trachyspermum ammi seeds in collagen induced arthritis in rats. Int. J. Drug Dev. & Res., 2012, 4(1), 210-219.
- Vaishnav, M.; Makim, R. Evaluation of Effect of Trachyspermum ammi Extract on Primary Dysmenorrhoea. Annals of R.S.C.B., 2020, 24(2), 1233-1237.
- Samadipour, E.; Rakhshani, M.H.; Kooshki, A.; Amin, B. Local Usage of Nigella sativa Oil as an Innovative Method to Attenuate Primary Dysmenorrhea: A Randomized Double-blind Clinical Trial. Oman Med. J., 2020, 35(5), e167. doi: 10.5001/omj.2020.109 PMID: 32953142
- Hajhashemi, V.; Ghannadi, A.; Jafarabadi, H. Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother. Res., 2004, 18(3), 195-199. doi: 10.1002/ptr.1390 PMID: 15103664
- Omidvar, S.; Esmailzadeh, S.; Baradaran, M.; Basirat, Z. Effect of fennel on pain intensity in dysmenorrhoea: A placebo-controlled trial. Ayu, 2012, 33(2), 311-313. doi: 10.4103/0974-8520.105259 PMID: 23559811
- Heidarifar, R.; Mehran, N.; Heidari, A.; Koohbor, M. Mansourabad, MK Effect of Dill Anethum graveolens on the severity of primary dysmenorrhea in compared with mefenamic acid: A randomized, double-blind trial. J res med sci., 2014, 19(4), 326.
- Kazemi, M. Phenolic profile, antioxidant capacity and anti-inflammatory activity of Anethum graveolens L. essential oil. Nat. Prod. Res., 2015, 29(6), 551-553. doi: 10.1080/14786419.2014.951934 PMID: 25154406
- Pundarikakshudu, K.; Shah, D.; Panchal, A.; Bhavsar, G. Anti-inflammatory activity of fenugreek (Trigonella foenum-graecum Linn) seed petroleum ether extract. Indian J. Pharmacol., 2016, 48(4), 441-444. doi: 10.4103/0253-7613.186195 PMID: 27756958
- Younesy, S.; Amiraliakbari, S.; Esmaeili, S.; Alavimajd, H.; Nouraei, S. Effects of fenugreek seed on the severity and systemic symptoms of dysmenorrhea. J. Reprod. Infertil., 2014, 15(1), 41-48. PMID: 24695380
- K, A.; Sultana, A.; Rahman, K. A single-blind randomized comparative study of Asafoetida vs Mefenamic acid in dysmenorrhea, associated symptoms and health-related quality of life. J. Herb. Med., 2017, 9, 21-31. doi: 10.1016/j.hermed.2017.06.003
- Bagheri, S.M.; Hedesh, S.T.; Mirjalili, A.; Dashti-R, M.H. Evaluation of anti-inflammatory and some possible mechanisms of antinociceptive effect of Ferula assa foetida oleo gum resin. J. Evid. Based Complementary Altern. Med., 2016, 21(4), 271-276. doi: 10.1177/2156587215605903 PMID: 26427790
- Nazari, M.; Rostami-Moez, M.; Ebrahimi, F. The effect of fennel on pain relief in primary dysmenorrhea: A systematic review of clinical trials. Int. J. Epidemiol. Res., 2020, 7(1), 44-48. doi: 10.34172/ijer.2020.08
- Ostad, S.N.; Soodi, M.; Shariffzadeh, M.; Khorshidi, N.; Marzban, H. The effect of fennel essential oil on uterine contraction as a model for dysmenorrhea, pharmacology and toxicology study. J. Ethnopharmacol., 2001, 76(3), 299-304. doi: 10.1016/S0378-8741(01)00249-5 PMID: 11448553
- Amirsalari, S.; Behboodi Moghadam, Z.; Taghizadeh, Z.; Jafar Abadi, M.N.; Sabaghzadeh Irani, P.; Goodarzi, S.; Ranjbar, H. The effect of garlic tablets on the endometriosis-related pains: a randomized placebo-controlled clinical trial. Evid. Based Complement. Alternat. Med., 2021, 2021, 1-8. doi: 10.1155/2021/5547058 PMID: 34335819
- Jayanthi, M.K.; Dhar, M.; Jayanthi, M. Anti-inflammatory effects of Allium sativum (garlic) in experimental rats. Biomedicine (Taipei), 2011, 31(1), 84-89.
- Bahrami, A.; Zarban, A.; Rezapour, H.; Agha Amini Fashami, A.; Ferns, G.A. Effects of curcumin on menstrual pattern, premenstrual syndrome, and dysmenorrhea: A triple‐blind, placebo‐controlled clinical trial. Phytother. Res., 2021, 35(12), 6954-6962. doi: 10.1002/ptr.7314 PMID: 34708460
Supplementary files
